Illustrative image – not actual.Intas Pharmaceuticals plans to expand the capacities of its plant at Matoda and Vatva in Gujarat, with an investment of Rs.150 crore in the next five years. The company plans to fund this expansion project through private placement, initial public offering and internal accruals.
Presently, the company has a capacity of 270 million capsules, 1,800 million tablets, 24 million vials and 42 million ampules of injectables.
